Investor insights
Sectors invested in
Funding rounds participated in
$33M sweet spot round size
Most of their 25 investments are in rounds between $17M and $50M
Investor type
Basic info
Sectors
Date founded
1978
Investments made
Autobahn Therapeutics, Inc. raised $33M on September 8, 2022
Investors: The Invus Group, ARCH Venture Partners, Samsara BioCapital, Bristol-Myers Squibb, UK, Section 32 and Biogen Idec
Sage Therapeutics raised $650M on November 27, 2020
Investors: Biogen Idec
Autobahn Therapeutics, Inc. raised $76M on June 11, 2020
Investors: The Invus Group, ARCH Venture Partners, Section 32, Bristol-Myers Squibb, UK, Samsara BioCapital and Biogen Idec
CAMP4 Therapeutics raised $15M on January 13, 2020
Investors: Biogen Idec
Samsung Bioepis raised $674M on June 28, 2018
Investors: Biogen Idec
Neurimmune AG raised $150M on October 25, 2017
Investors: Biogen Idec
Undisclosed raised $50M on March 30, 2017
Investors: Leerink Partners LLC, Research Division, Foresite Capital, RTW Investments, LP, RA Capital Management, L.P., Perceptive Advisors and Biogen Idec
Rodin Therapeutics raised $17M on January 6, 2016
Investors: Atlas Venture and Biogen Idec
True North Therapeutics raised $22M on June 17, 2014
Investors: Kleiner Perkins, S.R. One Ltd, MPM Capital and Biogen Idec
Ataxion, Inc. raised $17M on March 17, 2014
Investors: Atlas Venture and Biogen Idec
Funding rounds raised
Total raised
$1.5B
from 1 investors over 1 rounds
Biogen Idec raised $1.5B on September 1, 2023
Investors: J.P. Morgan